Psychiatric Illnesses Associated with Perseveration
Schizophrenia is the psychiatric illness most strongly associated with perseveration, characterized by a failure to generate new plans and responses, particularly in patients with the psychomotor poverty subsyndrome. 1, 2
Primary Psychiatric Conditions Associated with Perseveration
Schizophrenia
- Perseveration is widely observed in schizophrenia patients using various assessment instruments 1
- Associated with frontal lobe impairment and failure to generate new plans 2
- Correlates with negative symptoms and psychomotor poverty subsyndrome 2
- Manifests as continued reselection of previously activated outputs during tasks requiring controlled information processing 3
Frontotemporal Dementia
Autism Spectrum Disorder with PTEN Mutations
Bipolar Disorder
Borderline Personality Disorder
Neurobiological Basis of Perseveration
Perseveration appears to result from:
Frontal Lobe Dysfunction
Executive Control System Failure
Abnormal Response Plasticity
Clinical Patterns of Perseveration
Different psychiatric conditions show distinct perseveration patterns:
Negative Symptom Schizophrenia
Positive Symptom Schizophrenia
Autism with PTEN Mutations
Assessment of Perseveration
Multiple assessment methods provide complementary information:
Wisconsin Card Sorting Test (WCST)
Rorschach Perseveration Scale
California Verbal Learning Test (CVLT)
- Can help distinguish between failure to generate vs. execute plans 2
Clinical Implications
- Perseveration assessment can aid in differential diagnosis between psychiatric conditions
- Different types of perseveration (classic perseveration vs. over-switching) may help distinguish between positive and negative symptom schizophrenia 7
- Understanding the specific nature of perseveration (failure to generate plans vs. failure to execute plans) can guide treatment approaches 2
- Antipsychotic medication type (typical vs. atypical) does not appear to significantly impact perseveration in schizophrenia 2
Perseveration represents an important clinical marker that reflects underlying neurocognitive deficits, particularly in frontal lobe function, and is most prominently associated with schizophrenia, especially the negative symptom/psychomotor poverty subtype.